ES2178479T3 - Concentrado de principio activo con formoterol, apto para el almacenamiento. - Google Patents

Concentrado de principio activo con formoterol, apto para el almacenamiento.

Info

Publication number
ES2178479T3
ES2178479T3 ES99948972T ES99948972T ES2178479T3 ES 2178479 T3 ES2178479 T3 ES 2178479T3 ES 99948972 T ES99948972 T ES 99948972T ES 99948972 T ES99948972 T ES 99948972T ES 2178479 T3 ES2178479 T3 ES 2178479T3
Authority
ES
Spain
Prior art keywords
formoterol
concentrate
storage
active principle
free
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99948972T
Other languages
English (en)
Inventor
Dieter Hochrainer
Bernd Zierenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Boehringer Ingelheim Pharmaceuticals Inc
Original Assignee
Boehringer Ingelheim Pharma GmbH and Co KG
Boehringer Ingelheim Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19847969A external-priority patent/DE19847969A1/de
Application filed by Boehringer Ingelheim Pharma GmbH and Co KG, Boehringer Ingelheim Pharmaceuticals Inc filed Critical Boehringer Ingelheim Pharma GmbH and Co KG
Application granted granted Critical
Publication of ES2178479T3 publication Critical patent/ES2178479T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Concentrado de principio activo exento de agente propulsor, apto para almacenar, para la preparación de una formulación de aerosol, exenta de agente propulsor, la cual, como principio activo, contiene formoterol en forma de su base libre, una de sus sales farmacológicamente compatibles o uno de sus productos de adición en un disolvente o agente de suspensión farmacológicamente compatible, estando comprendida la concentración de formoterol entre 75 mg/ml y 500 mg/ml.
ES99948972T 1998-10-17 1999-10-09 Concentrado de principio activo con formoterol, apto para el almacenamiento. Expired - Lifetime ES2178479T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19847969A DE19847969A1 (de) 1998-10-17 1998-10-17 Lagerfähig flüssige Formulierung mit Formoterol
US11238098P 1998-12-14 1998-12-14

Publications (1)

Publication Number Publication Date
ES2178479T3 true ES2178479T3 (es) 2002-12-16

Family

ID=26049594

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99948972T Expired - Lifetime ES2178479T3 (es) 1998-10-17 1999-10-09 Concentrado de principio activo con formoterol, apto para el almacenamiento.

Country Status (26)

Country Link
EP (1) EP1121112B1 (es)
JP (2) JP3636430B2 (es)
KR (1) KR100655100B1 (es)
CN (1) CN1187044C (es)
BG (1) BG65350B1 (es)
BR (1) BR9914507A (es)
CA (1) CA2343123C (es)
CZ (1) CZ20011362A3 (es)
DE (1) DE59901669D1 (es)
DK (1) DK1121112T3 (es)
EA (1) EA003960B1 (es)
EE (1) EE04219B1 (es)
ES (1) ES2178479T3 (es)
HK (1) HK1041448B (es)
HR (1) HRP20010255A2 (es)
HU (1) HUP0103925A3 (es)
ID (1) ID29605A (es)
IL (2) IL142494A0 (es)
NO (1) NO20011663D0 (es)
NZ (1) NZ511225A (es)
PL (1) PL348434A1 (es)
PT (1) PT1121112E (es)
SI (1) SI1121112T1 (es)
SK (1) SK285382B6 (es)
TR (1) TR200101096T2 (es)
WO (1) WO2000023065A2 (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
JP5392880B2 (ja) * 2000-05-22 2014-01-22 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
US6667344B2 (en) * 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) * 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
ITRM20040268A1 (it) * 2004-05-31 2004-08-31 Italchimici S P A Formulazione farmaceutica di una soluzione stabile di formoterolo per via inalatoria e suo precedimento di preparazione.
ITRM20050022A1 (it) 2005-01-19 2006-07-20 Italchimici S P A Formulazione farmaceutica di una soluzione stabile di glicole propilenico contenente formoterolo per via inalatoria e suo procedimento di preparazione.
WO2007059620A1 (en) * 2005-11-23 2007-05-31 Feanny Stephen J Method for administering formoterol using a nebulizer
DE102006023756A1 (de) * 2006-05-20 2007-11-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ethanolhaltige Aerosolformulierung für die Inhalation
AU2007267523B2 (en) * 2006-05-26 2012-02-09 Dey, L.P. Nebulizable compositions of quaternary ammonium muscarinic receptor antagonists
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
WO2010133294A2 (de) 2009-05-18 2010-11-25 Boehringer Ingelheim International Gmbh Adapter, inhalationseinrichtung und zerstäuber
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
EA026241B1 (ru) 2009-11-25 2017-03-31 Бёрингер Ингельхайм Интернациональ Гмбх Распылитель
WO2011160932A1 (en) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Nebulizer
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
PL2835146T3 (pl) 2013-08-09 2021-04-06 Boehringer Ingelheim International Gmbh Nebulizator
EP3030298B1 (en) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Nebulizer
HUE055604T2 (hu) 2014-05-07 2021-12-28 Boehringer Ingelheim Int Porlasztó
AU2015257878B2 (en) 2014-05-07 2019-08-08 Boehringer Ingelheim International Gmbh Container, nebulizer and use
EA035261B1 (ru) 2014-05-07 2020-05-21 Бёрингер Ингельхайм Интернациональ Гмбх Небулайзер и контейнер
CN107362140A (zh) * 2016-05-11 2017-11-21 广东东阳光药业有限公司 喷雾剂以及喷雾组件
CN116173025A (zh) * 2018-07-26 2023-05-30 四川海思科制药有限公司 一种含格隆铵盐及茚达特罗盐的气雾剂药物组合物及其制备方法与应用
CN110755414A (zh) * 2019-11-12 2020-02-07 南京华盖制药有限公司 一种酒石酸阿福特罗气雾剂及其制备方法
FI4188327T3 (fi) * 2020-07-31 2025-07-25 Chemo Res S L Yhdistelmähoito inhalaatioannosteluun

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0617610B1 (en) * 1991-12-18 1997-03-19 Minnesota Mining And Manufacturing Company Suspension aerosol formulations
GB9612297D0 (en) * 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
GB9616237D0 (en) * 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations

Also Published As

Publication number Publication date
DK1121112T3 (da) 2002-09-16
CN1187044C (zh) 2005-02-02
EE200100224A (et) 2002-06-17
BG65350B1 (bg) 2008-03-31
NO20011663L (no) 2001-04-03
PT1121112E (pt) 2002-11-29
EP1121112A2 (de) 2001-08-08
KR100655100B1 (ko) 2006-12-08
CZ20011362A3 (cs) 2001-09-12
BG105391A (bg) 2001-11-30
EA200100439A1 (ru) 2001-10-22
HUP0103925A2 (hu) 2002-05-29
EE04219B1 (et) 2004-02-16
IL142494A0 (en) 2002-03-10
WO2000023065A2 (de) 2000-04-27
NO20011663D0 (no) 2001-04-03
CA2343123C (en) 2008-03-25
HUP0103925A3 (en) 2003-05-28
WO2000023065A8 (de) 2001-02-22
SI1121112T1 (sl) 2002-10-31
ID29605A (id) 2001-09-06
WO2000023065A3 (de) 2000-08-03
JP2002527473A (ja) 2002-08-27
BR9914507A (pt) 2001-06-26
HK1041448A1 (en) 2002-07-12
EP1121112B1 (de) 2002-06-05
PL348434A1 (en) 2002-05-20
HK1041448B (zh) 2005-05-13
NZ511225A (en) 2003-08-29
CN1333682A (zh) 2002-01-30
EA003960B1 (ru) 2003-10-30
SK285382B6 (sk) 2006-12-07
IL142494A (en) 2006-04-10
CA2343123A1 (en) 2000-04-27
HRP20010255A2 (en) 2002-04-30
JP2005047933A (ja) 2005-02-24
TR200101096T2 (tr) 2001-12-21
JP3636430B2 (ja) 2005-04-06
SK4942001A3 (en) 2001-09-11
KR20010075637A (ko) 2001-08-09
DE59901669D1 (de) 2002-07-11

Similar Documents

Publication Publication Date Title
ES2178479T3 (es) Concentrado de principio activo con formoterol, apto para el almacenamiento.
CO5261514A1 (es) Composicion liquida que contiene formoterol
NO2025027I1 (no) Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - forlenget.
AR033808A1 (es) Una composicion topica de anestesia local y los parches y los envases que la contienen
UY26372A1 (es) "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
BRPI0412975A (pt) espuma penetrante para uso farmacêutico
CL2010000816A1 (es) Formulacion adecuada para administracion subcutanea que comprende al menos 100 mg/ml de ctlaig, un azucar, y un portador acuoso farmaceuticamente estable; articulo de fabricacion que comprende al menos un recipiente que contiene la formulacion antes mencionada. (divisional solicitud n° 3597-06)
AR019690A1 (es) Formulacion farmaceutica para aerosoles con dos o mas sustancias activas
CY1105262T1 (el) Φαρμακευτικες συνθεσεις παρατεταμενης απελευθερωσης για την παρεντepικη χορηγηση βιολογικως δραστικων υδροφιλων ενωσεων
ES2189410T3 (es) Formulacion farmaceutica en aerosol.
ES2159591T3 (es) Composicion de liberacion controlada.
AR031162A1 (es) Surtidor de medicamento y su uso
ATE460921T1 (de) Medikamenthaltige zusammensetzung in aerosolform
ES2182357T3 (es) Nueva utilizacion de budesonide y formoterol.
GT200200065A (es) Composicion parenteral reconstituible
AR042977A1 (es) Formulaciones farmaceuticas liquidas de palonosetron
AR053541A1 (es) Combinacion de xolair con agente inmunosupresor
ES2174293T3 (es) Microesferas farmaceuticas de acido valproico para la administracion oral.
ES2179533T3 (es) Formulacion de medicamento con liberacion controlada del principio activo.
PE20070377A1 (es) Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol
ATE289276T1 (de) Kanister enthaltend eine wirkstoff-formulierung mit fluorkohlenwasserstoff als treibmittel
AR022773A1 (es) Emulsiones pit y procedimiento para la elaboracion de emulsiones de pesticidas
CO4970832A1 (es) Nuevas formulaciones y procesos para su fabricacion
DE69933671D1 (de) Adenosin a1 antagonisten gegen männliche sterilität
AR043016A2 (es) Un compuesto antimigranico eletriptan y composicion farmaceutica que lo contiene